miR-501-3p from osteosarcoma cell-derived exosomes promotes osteoclast differentiation by inhibiting PTEN expression and activating the PI3K/Akt signaling pathway, exacerbating bone loss, providing a new target for the clinical diagnosis and treatment of osteosarcoma [94]. Here, AKT1 is linked to osteosarcoma.